Oridonin inhibits inflammation of epithelial cells via dual-targeting of CD31 Keap1 to ameliorate acute lung injury

Introdcution Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are major causes of COVID-19 mortality. However, drug delivery to lung tissues is impeded by endothelial cell barriers, limiting the efficacy of existing treatments. A prompt and aggressive treatment strategy is therefore necessary. Methods We assessed the ability of anti-CD31-ORI-NPs to penetrate endothelial cell barriers and specifically accumulate in lung tissues using an animal model. We also compared the efficacy of anti-CD31-ORI-NPs to that of free oridonin in ameliorating acute lung injury and evaluated the cytotoxicity of both treatments on endothelial cells. Results Compared to free ORI, the amount of anti-CD31-ORI-NPs accumulated in lung tissues increase at least three times. Accordingly, anti-CD31-ORI-NPs improve the efficacy three times on suppressing IL-6 and TNF-a secretion, ROS production, eventually ameliorating acute lung injury in animal model. Importantly, anti-CD31-ORI-NPs significantly decrease the cytotoxicity at least two times than free oridonin on endothelial cells. Discussion Our results from this study will not only offer a novel therapeutic strategy with high efficacy and low toxicity, but also provide the rational design of nanomaterials of a potential drug for acute lung injury therapy.

[1]  C. Evans,et al.  Oridonin-Loaded Nanoparticles Inhibit Breast Cancer Progression Through Regulation of ROS-Related Nrf2 Signaling Pathway , 2021, Frontiers in Bioengineering and Biotechnology.

[2]  H. Ullum,et al.  Compartmental immunophenotyping in COVID-19 ARDS: A case series , 2020, Journal of Allergy and Clinical Immunology.

[3]  P. Saldiva,et al.  SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology , 2020, The Journal of experimental medicine.

[4]  Arthur S Slutsky,et al.  Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study , 2020, The Lancet Respiratory Medicine.

[5]  Pratik Sinha,et al.  Is a "Cytokine Storm" Relevant to COVID-19? , 2020, JAMA internal medicine.

[6]  Axel Haverich,et al.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.

[7]  J. M. Crawford,et al.  Targeting potential drivers of COVID-19: Neutrophil extracellular traps , 2020, The Journal of experimental medicine.

[8]  B. Joe,et al.  Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease , 2020, Physiological genomics.

[9]  Xuetao Cao.  COVID-19: immunopathology and its implications for therapy , 2020, Nature Reviews Immunology.

[10]  R. Radhakrishnan,et al.  Therapeutic Effect of Oridonin Against Inflammatory Bowel Disease Involves Inhibition of Intestinal Fibrosis via NF‐κB Pathway , 2020, The FASEB Journal.

[11]  Xin Zhou,et al.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.

[12]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[13]  D. Irvine,et al.  Enhancing cancer immunotherapy with nanomedicine , 2020, Nature Reviews Immunology.

[14]  Bin Xu,et al.  Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling , 2019, OncoTargets and therapy.

[15]  X. Ci,et al.  Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways , 2019, Cell Communication and Signaling.

[16]  Zhenjie Liu,et al.  Novel Paracrine Functions of Smooth Muscle Cells in Supporting Endothelial Regeneration Following Arterial Injury , 2019, Circulation research.

[17]  H. Schluesener,et al.  Natural Diterpenoid Oridonin Ameliorates Experimental Autoimmune Neuritis by Promoting Anti-inflammatory Macrophages Through Blocking Notch Pathway , 2019, Front. Neurosci..

[18]  Pengfei Li,et al.  Exosomes from endothelial progenitor cells improve outcomes of the lipopolysaccharide-induced acute lung injury , 2019, Critical Care.

[19]  M. I. Setyawati,et al.  Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness , 2019, Nature Nanotechnology.

[20]  Joyce S Lee,et al.  Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis , 2018, American journal of respiratory and critical care medicine.

[21]  C. Scott,et al.  Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapy. , 2018, Drug discovery today. Technologies.

[22]  Luis M Liz-Marzán,et al.  Cellular Uptake of Nanoparticles versus Small Molecules: A Matter of Size. , 2018, Accounts of chemical research.

[23]  Qingsong Liu,et al.  Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity , 2018, Nature Communications.

[24]  Peiwei Gong,et al.  Fluorinated graphene as an anticancer nanocarrier: an experimental and DFT study. , 2018, Journal of materials chemistry. B.

[25]  Zhuang Liu,et al.  Polydopamine nanoparticles for the treatment of acute inflammation-induced injury. , 2018, Nanoscale.

[26]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .

[27]  J. Pober,et al.  Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys , 2017, Science Translational Medicine.

[28]  Jingying Liu,et al.  Protein-gold nanoparticle interactions and their possible impact on biomedical applications. , 2017, Acta biomaterialia.

[29]  F. Aboitiz.  A Matter of Size , 2017 .

[30]  W. Muller.  Transendothelial migration: unifying principles from the endothelial perspective , 2016, Immunological reviews.

[31]  Jiye Cai,et al.  Folate-Chitosan Nanoparticles Loaded with Ursolic Acid Confer Anti-Breast Cancer Activities in vitro and in vivo , 2016, Scientific Reports.

[32]  M. Griffiths,et al.  The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities , 2016, Thorax.

[33]  O. Thaunat.  Soothing touch of CD31 protects endothelium during cellular immune responses , 2015, Proceedings of the National Academy of Sciences.

[34]  Ying Li,et al.  Shape effect in cellular uptake of PEGylated nanoparticles: comparison between sphere, rod, cube and disk. , 2015, Nanoscale.

[35]  S. Bonini,et al.  Barriers to new drug development in respiratory disease , 2015, European Respiratory Journal.

[36]  Zuyi Weng,et al.  The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells. , 2015, The Journal of allergy and clinical immunology.

[37]  Andrew J. Robles,et al.  Corrigendum: Crowdsourcing Natural Products Discovery to Access Uncharted Dimensions of Fungal Metabolite Diversity. , 2015, Angewandte Chemie.

[38]  V. Muzykantov,et al.  ICAM-1 Targeted Nanogels Loaded with Dexamethasone Alleviate Pulmonary Inflammation , 2014, PloS one.

[39]  Warren C. W. Chan,et al.  Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting. , 2014, Angewandte Chemie.

[40]  Lin Du,et al.  Crowdsourcing natural products discovery to access uncharted dimensions of fungal metabolite diversity. , 2014, Angewandte Chemie.

[41]  Jianlin Shi,et al.  MSN Anti‐Cancer Nanomedicines: Chemotherapy Enhancement, Overcoming of Drug Resistance, and Metastasis Inhibition , 2014, Advanced materials.

[42]  Haihua Feng,et al.  Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo. , 2012, Journal of agricultural and food chemistry.

[43]  Baek Kim,et al.  Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages. , 2012, International immunopharmacology.

[44]  Fengyi Zhang,et al.  PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. , 2011, Journal of agricultural and food chemistry.

[45]  Dorota Bartczak,et al.  Preparation of peptide-functionalized gold nanoparticles using one pot EDC/sulfo-NHS coupling. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[46]  B. Amulic,et al.  Neutrophil extracellular traps , 2011, Current Biology.

[47]  M. McMahon,et al.  p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription* , 2010, The Journal of Biological Chemistry.

[48]  B. Preston,et al.  Case Series , 2010, Toxicologic pathology.

[49]  H. Rabb,et al.  Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. , 2004, American journal of respiratory and critical care medicine.

[50]  C. Buckley,et al.  CD31 Regulates Direction and Rate of Neutrophil Migration over and under Endothelial Cells , 2003, Journal of Vascular Research.

[51]  S. Gautam,et al.  Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. , 1997, Hematopathology and molecular hematology.

[52]  C. Kuiken,et al.  Characterization of the African HIV-1 isolate CBL-4 (RUT) by partial sequence analysis and virus neutralization with peptide antibody and antisense phosphate-methylated DNA. , 1990, AIDS.